Onpattro Market Report 2026
Onpattro Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Onpattro Market Report 2026

Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Onpattro Market Overview

• The Onpattro market growth in the historic period has been driven by advancements in rna-based drug development, increased diagnosis of hATTR amyloidosis

• Market expansion is supported by expansion of next-generation rna therapeutics, increasing investments in rare disease pipelines

• Growth Driver: Impact Of Rising Prevalence Of Hereditary Transthyretin-Mediated Amyloidosis On The Onpattro Market Growth

• Market Trend: Broadening Patient Access Through Strategic Drug Approvals

North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Onpattro Market?

Onpattro (patisiran) is an FDA-approved medication used to treat hereditary transthyretin-mediated amyloidosis (hATTR), a rare genetic disorder. It works by targeting and silencing the transthyretin (TTR) gene to reduce the production of amyloid proteins that cause organ damage. Onpattro is delivered via intravenous infusion and helps manage symptoms and improve the quality of life for affected patients.

The main clinical indications of onpattro are hereditary transthyretin-mediated amyloidosis, wild-type transthyretin amyloidosis, and other transthyretin-related amyloidoses. Hereditary transthyretin-mediated amyloidosis is a genetic disorder caused by mutations in the transthyretin (TTR) gene, leading to abnormal TTR protein production. These proteins accumulate as amyloid deposits in organs, most notably the heart and nerves, causing progressive damage. It is distributed through various distribution channels, such as direct sales, pharmacies, and online pharmacies, and used by several end users, including hospitals, specialty clinics, and home healthcare providers.

Onpattro Market Global Report 2026 Market Report bar graph

What Is The Onpattro Market Size and Share 2026?

The growth in the historic period can be attributed to advancements in rna-based drug development, increased diagnosis of hATTR amyloidosis, regulatory approvals for gene-silencing therapies, expansion of specialty infusion centers, clinical validation of patisiran efficacy.

What Is The Onpattro Market Growth Forecast?

The growth in the forecast period can be attributed to expansion of next-generation rna therapeutics, increasing investments in rare disease pipelines, growing focus on personalized medicine, development of subcutaneous delivery alternatives, rising adoption of genetic screening programs. Major trends in the forecast period include increasing adoption of rna interference therapies, rising focus on rare genetic disease treatment, expansion of precision gene silencing approaches, improved clinical outcomes in amyloidosis care, growing integration of advanced infusion therapies.

Customer representative image Book your 30 minutes free consultation with our research experts

Global Onpattro Market Segmentation

1) By Clinical Indication: Hereditary Transthyretin-Mediated Amyloidosis, Wild-Type Transthyretin Amyloidosis, Other Transthyretin-Related Amyloidoses

2) By Distribution Channel: Direct Sales, Pharmacies, Online Pharmacies

3) By End User: Hospitals, Specialty Clinics, Home Healthcare Providers

What Is The Driver Of The Onpattro Market?

The rising prevalence of hereditary transthyretin-mediated amyloidosis is expected to propel the growth of the onpattro market going forward. Hereditary transthyretin-mediated amyloidosis (hATTR) is a rare genetic disorder where mutated TTR proteins form harmful deposits, affecting nerves and the heart. The rising prevalence of hereditary transthyretin-mediated amyloidosis is driven by better diagnostics, genetic testing, and increasing awareness, identifying more cases. Onpattro is used to treat hereditary transthyretin-mediated amyloidosis by silencing the transthyretin (TTR) gene to reduce amyloid protein production and prevent organ damage. For instance, in February 2024, according to Verywell Health, a US-based health information platform, Globally, hereditary transthyretin-mediated amyloidosis affects 5,500–38,500 individuals, with U.S. estimates ranging from 104 to 3,847 cases of hereditary transthyretin-mediated amyloidosis with polyneuropathy, highlighting significant underdiagnosis. Therefore, the rising prevalence of hereditary transthyretin-mediated amyloidosis is driving the growth of the onpattro industry.

Key Players In The Global Onpattro Market

Major companies operating in the onpattro market are Alnylam Pharmaceuticals Inc.

Global Onpattro Market Trends and Insights

The key trend in the onpattro market is focused on expanding the drug’s indications through supplemental drug applications, aiming to maximize market potential and meet a wider range of patient needs. Supplemental drug applications generally aim to extend the approved uses of a drug, such as targeting new indications, populations, or formulations, to broaden its therapeutic reach and market potential. For instance, in February 2023, Alnylam Pharmaceuticals, a US-based pharmaceutical company, announced the acceptance of a Supplemental New Drug Application (sNDA) for ONPATTRO (patisiran). This treatment targets cardiomyopathy associated with transthyretin amyloidosis (ATTR). ONPATTRO is an RNA interference (RNAi) therapeutic designed to specifically target the transthyretin (TTR) protein, which can accumulate abnormally in patients with ATTR amyloidosis, leading to severe complications such as cardiomyopathy. The drug was initially approved in 2018 for the treatment of polyneuropathy related to hereditary ATTR amyloidosis. The recent sNDA submission was based on results from the Phase III APOLLO-B study, which demonstrated that patisiran significantly improved functional capacity and quality of life in patients with cardiomyopathy compared to a placebo.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Onpattro Market?

In March 2023, Alnylam Pharmaceuticals, a US-based biopharmaceutical company, partnered with Medison Pharma to expand the availability and commercialization of RNAi therapeutics in Central and Eastern Europe. This partnership aims to enhance the commercialization of Alnylam's RNAi therapeutics, including ONPATTRO (patisiran), which is designed for the treatment of hereditary transthyretin-mediated amyloidosis (hATTR) in adults with stage 1 or stage 2 polyneuropathy Medison Pharma is an Israel-based biopharmaceutical company that specializes in the commercialization and distribution of innovative therapies.

Regional Insights

North America was the largest region in the onpattro market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Onpattro Market?

The onpattro market consists of sales of lipids, drug delivery systems, and supportive diagnostic tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Onpattro Market Report 2026?

The onpattro market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the onpattro industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Onpattro Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $ billion
Revenue Forecast In 2035 $ billion
Growth Rate No CAGR found from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Clinical Indication, Distribution Channel, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Alnylam Pharmaceuticals Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Onpattro Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Onpattro Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Onpattro Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Onpattro Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Increasing Adoption Of Rna Interference Therapies

4.2.2 Rising Focus On Rare Genetic Disease Treatment

4.2.3 Expansion Of Precision Gene Silencing Approaches

4.2.4 Improved Clinical Outcomes In Amyloidosis Care

4.2.5 Growing Integration Of Advanced Infusion Therapies

5. Onpattro Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Infusion Centers

5.4 Home Healthcare Providers

5.5 Rare Disease Treatment Centers

6. Onpattro Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Onpattro Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Onpattro PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Onpattro Market Size, Comparisons And Growth Rate Analysis

7.3. Global Onpattro Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Onpattro Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Onpattro Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Onpattro Market Segmentation

9.1. Global Onpattro Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hereditary Transthyretin-Mediated Amyloidosis, Wild-Type Transthyretin Amyloidosis, Other Transthyretin-Related Amyloidoses

9.2. Global Onpattro Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Direct Sales, Pharmacies, Online Pharmacies

9.3. Global Onpattro Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Specialty Clinics, Home Healthcare Providers

10. Onpattro Market Regional And Country Analysis

10.1. Global Onpattro Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Onpattro Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Onpattro Market

11.1. Asia-Pacific Onpattro Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Onpattro Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Onpattro Market

12.1. China Onpattro Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Onpattro Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Onpattro Market

13.1. India Onpattro Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Onpattro Market

14.1. Japan Onpattro Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Onpattro Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Onpattro Market

15.1. Australia Onpattro Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Onpattro Market

16.1. South Korea Onpattro Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

16.2. South Korea Onpattro Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Onpattro Market

17.1. Western Europe Onpattro Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. Western Europe Onpattro Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Onpattro Market

18.1. UK Onpattro Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Onpattro Market

19.1. Germany Onpattro Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Onpattro Market

20.1. France Onpattro Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Onpattro Market

21.1. Eastern Europe Onpattro Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

21.2. Eastern Europe Onpattro Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Onpattro Market

22.1. North America Onpattro Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

22.2. North America Onpattro Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Onpattro Market

23.1. USA Onpattro Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

23.2. USA Onpattro Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Onpattro Market

24.1. Canada Onpattro Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

24.2. Canada Onpattro Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Onpattro Market

25.1. South America Onpattro Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

25.2. South America Onpattro Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Onpattro Market

26.1. Middle East Onpattro Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Middle East Onpattro Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Onpattro Market

27.1. Africa Onpattro Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

27.2. Africa Onpattro Market, Segmentation By Clinical Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Onpattro Market Regulatory and Investment Landscape

29. Onpattro Market Competitive Landscape And Company Profiles

29.1. Onpattro Market Competitive Landscape And Market Share 2024

29.1.1. Top 10 Companies (Ranked by revenue/share)

29.2. Onpattro Market - Company Scoring Matrix

29.2.1. Market Revenues

29.2.2. Product Innovation Score

29.2.3. Brand Recognition

29.3. Onpattro Market Company Profiles

29.3.1. Alnylam Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

30. Global Onpattro Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Onpattro Market

32. Onpattro Market High Potential Countries, Segments and Strategies

32.1 Onpattro Market In 2030 - Countries Offering Most New Opportunities

32.2 Onpattro Market In 2030 - Segments Offering Most New Opportunities

32.3 Onpattro Market In 2030 - Growth Strategies

32.3.1 Market Trend Based Strategies

32.3.2 Competitor Strategies

33. Appendix

33.1. Abbreviations

33.2. Currencies

33.3. Historic And Forecast Inflation Rates

33.4. Research Inquiries

33.5. The Business Research Company

33.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Onpattro Market, Overview Of Key Products - Product Examples
  • Table 2: Global Onpattro Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Onpattro Market, Supply Chain Analysis
  • Table 4: Global Onpattro Market, Major Raw Material Providers
  • Table 5: Global Onpattro Market, Major Resource Providers
  • Table 6: Global Onpattro Market, Major Manufacturers (Suppliers)
  • Table 7: Global Onpattro Market, Major Distributors And Channel Partners
  • Table 8: Global Onpattro Market, Key Technologies & Future Trends
  • Table 9: Global Onpattro Market, Major Trends
  • Table 10: Global Onpattro Market, Major End Users
  • Table 11: Global Onpattro Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Onpattro Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Onpattro Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Onpattro Market - TAM, US$ Billion, 2025
  • Table 15: Global Onpattro Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Onpattro Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Onpattro Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Onpattro Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Onpattro Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Asia-Pacific, Onpattro Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Asia-Pacific, Onpattro Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Onpattro Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: China, Onpattro Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: China, Onpattro Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Onpattro Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: India, Onpattro Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: India, Onpattro Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Onpattro Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: Japan, Onpattro Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: Japan, Onpattro Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Onpattro Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Australia, Onpattro Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Australia, Onpattro Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Onpattro Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: South Korea, Onpattro Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: South Korea, Onpattro Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: South Korea, Onpattro Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Western Europe, Onpattro Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Western Europe, Onpattro Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Western Europe, Onpattro Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: UK, Onpattro Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: UK, Onpattro Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: UK, Onpattro Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Germany, Onpattro Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Germany, Onpattro Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Germany, Onpattro Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: France, Onpattro Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: France, Onpattro Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: France, Onpattro Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Eastern Europe, Onpattro Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Eastern Europe, Onpattro Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Eastern Europe, Onpattro Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: North America, Onpattro Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: North America, Onpattro Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: North America, Onpattro Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: USA, Onpattro Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: USA, Onpattro Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: USA, Onpattro Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Canada, Onpattro Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Canada, Onpattro Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Canada, Onpattro Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: South America, Onpattro Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: South America, Onpattro Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: South America, Onpattro Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Middle East, Onpattro Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Middle East, Onpattro Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Middle East, Onpattro Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Africa, Onpattro Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Africa, Onpattro Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Africa, Onpattro Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Global Onpattro Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 72: Global Onpattro Market - Company Scoring Matrix
  • Table 73: Alnylam Pharmaceuticals Inc. Financial Performance
  • Table 74: Global Onpattro Market, Competitive Benchmarking (In USD Billions)
  • Table 75: Global Onpattro Market, Competitive Dashboard
  • Table 76: Global Onpattro Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 77: Global, Onpattro Market Size Gain ($ Billion), Segmentation By Clinical Indication, 2025 – 2030
  • Table 78: Global, Onpattro Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030
  • Table 79: Global, Onpattro Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

List Of Figures

    Figure 1: Global Onpattro Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Onpattro Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Onpattro Market, Supply Chain Analysis
  • Figure 4: Global Onpattro Market, Major Raw Material Providers
  • Figure 5: Global Onpattro Market, Major Resource Providers
  • Figure 6: Global Onpattro Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Onpattro Market, Major Distributors And Channel Partners
  • Figure 8: Global Onpattro Market, Key Technologies & Future Trends
  • Figure 9: Global Onpattro Market, Major Trends
  • Figure 10: Global Onpattro Market, Major End Users
  • Figure 11: Global Onpattro Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Onpattro Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Onpattro Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Onpattro Market - TAM, US$ Billion, 2025
  • Figure 15: Global Onpattro Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Onpattro Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Onpattro Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Onpattro Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Onpattro Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Asia-Pacific, Onpattro Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Asia-Pacific, Onpattro Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Onpattro Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: China, Onpattro Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: China, Onpattro Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Onpattro Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: India, Onpattro Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: India, Onpattro Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Onpattro Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: Japan, Onpattro Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: Japan, Onpattro Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Onpattro Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Australia, Onpattro Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Australia, Onpattro Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Onpattro Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: South Korea, Onpattro Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: South Korea, Onpattro Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: South Korea, Onpattro Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Western Europe, Onpattro Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Western Europe, Onpattro Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Western Europe, Onpattro Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: UK, Onpattro Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: UK, Onpattro Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: UK, Onpattro Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Germany, Onpattro Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Germany, Onpattro Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Germany, Onpattro Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: France, Onpattro Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: France, Onpattro Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: France, Onpattro Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Eastern Europe, Onpattro Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Eastern Europe, Onpattro Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Eastern Europe, Onpattro Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: North America, Onpattro Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: North America, Onpattro Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: North America, Onpattro Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: USA, Onpattro Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: USA, Onpattro Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: USA, Onpattro Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Canada, Onpattro Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Canada, Onpattro Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Canada, Onpattro Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: South America, Onpattro Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: South America, Onpattro Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: South America, Onpattro Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Middle East, Onpattro Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Middle East, Onpattro Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Middle East, Onpattro Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Africa, Onpattro Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Africa, Onpattro Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Africa, Onpattro Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Global Onpattro Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 72: Global Onpattro Market - Company Scoring Matrix
  • Figure 73: Alnylam Pharmaceuticals Inc. Financial Performance
  • Figure 74: Global Onpattro Market, Competitive Benchmarking (In USD Billions)
  • Figure 75: Global Onpattro Market, Competitive Dashboard
  • Figure 76: Global Onpattro Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 77: Global, Onpattro Market Size Gain ($ Billion), Segmentation By Clinical Indication, 2025 – 2030
  • Figure 78: Global, Onpattro Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030
  • Figure 79: Global, Onpattro Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

Frequently Asked Questions

The Onpattro market was valued at $ billion in 2025, increased to $ billion in 2026, and is projected to reach $ billion by 2030.

The global Onpattro market is expected to grow at a CAGR of nan% from 2026 to 2035 to reach $ billion by 2035.

Some Key Players in the Onpattro market Include, Alnylam Pharmaceuticals Inc. .

Major trend in this market includes: Broadening Patient Access Through Strategic Drug Approvals. For further insights on this market. request a sample here

North America was the largest region in the onpattro market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the onpattro market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts